Dianthus Therapeutics
DNTH
DNTH
92 hedge funds and large institutions have $255M invested in Dianthus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 94 → 92 (-2)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
72% less call options, than puts
Call options by funds: $46K | Put options by funds: $164K
Holders
92
Holding in Top 10
2
Calls
$46K
Puts
$164K
Top Buyers
| 1 | +$10.3M | |
| 2 | +$1.67M | |
| 3 | +$1.25M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.06M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$923K |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$1.16M | |
| 3 | -$930K | |
| 4 |
Squarepoint
New York
|
-$415K |
| 5 |
UBS AM
Chicago,
Illinois
|
-$407K |